Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 17.172.661.5112.267.33

What is the latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS is 17.17 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202417.17
Mar20232.66
Mar20221.51
Mar202112.26
Mar20207.33

How is EV/Core EBITDA of SOTAC PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 17.17
545.49
Mar2023 2.66
76.16
Mar2022 1.51
-87.68
Mar2021 12.26
67.26
Mar2020 7.33 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹121.5 Cr -1.1% -20% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-1.1%

-20%

-8.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses